Vol. | Pool | Epitope no. | Sequence | HLA allele group | Control depl. sfc/m | CD8+ depl. sfc/m (%)* | CD4+ depl. sfc/m (%)* | CD8+ %** | CD4+ %** |
---|---|---|---|---|---|---|---|---|---|
V401 | Cp1 | Â | Â | Â | 97 | 5 (-95%) | 82 (-15%) | 0.44 | 0.02 |
 | E21 | SFLFVEALF | A*23:01 | 254 | 15 (-94%) | 226 (-11%) | 0.37 | 0.04 | |
 | E14 | SVFNVVNSSI | A*23:01 | 86 | 38 (-56%) | 43 (-50%) | 0.12 | 0.01 | |
 | E18 | LIMVLSFLF | A*23:01 | 236 | 23 (-90%) | 210 (-11%) | 0.54 | 0.02 | |
V692 | Cp1 | Â | Â | Â | 445 | 6 (-98%) | 397 (-11%) | 0.53 | 0.01 |
 | E2 | FVEALFQEY | B*35:01 | 380 | 17 (-96%) | 356 (-6%) | 0.48 | 0.00 | |
V1253 | Â | E20 | SVSSFLFV EA | A*02:01 | 79 | 72 (-9%) | 17 (-78%) | 0.06 | 0.02 |
V1563 | Cp1 | Â | Â | Â | 133 | 0 (-100%) | 135 (+2%) | 0.33 | 0.01 |
 | E21 | SFLFVEALF | A*29:02 | 213 | 29 (-86%) | 273 (+28%) | 0.25 | 0.01 | |
 | E1 | FLFVEALFQ E | A*29:02 | 245 | 91 (-73%) | 215 (-12%) | 0.34 | 0.03 | |
 | Cp9 | E18 | LIMVLSFLF | A*29:02 | 307 | 85 (-82%) | 264 (-18%) | 0.26 | 0.01 |